| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 18:33:54 UTC |
|---|
| Update Date | 2022-03-07 02:53:51 UTC |
|---|
| HMDB ID | HMDB0033801 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Demethoxycurcumin |
|---|
| Description | Demethoxycurcumin, also known as curcuminii or BHCFM, belongs to the class of organic compounds known as curcuminoids. These are aromatic compounds containing a curcumin moiety, which is composed of two aryl buten-2-one (feruloyl) chromophores joined by a methylene group. Demethoxycurcumin is found, on average, in the highest concentration within turmerics (Curcuma longa). Demethoxycurcumin has also been detected, but not quantified in, a few different foods, such as beverages, herbs and spices, and root vegetables. This could make demethoxycurcumin a potential biomarker for the consumption of these foods. Demethoxycurcumin is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Demethoxycurcumin. |
|---|
| Structure | COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(O)C=C2)=CC=C1O InChI=1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+ |
|---|
| Synonyms | | Value | Source |
|---|
| (1E,6E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione | ChEBI | | (1E,6E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-hepta-1,6-diene-3,5-dione | ChEBI | | 4-Hydroxycinnamoyl(feroyl)methane | ChEBI | | 4-Hydroxycinnamoyl(feruloyl)methane | ChEBI | | BHCFM | ChEBI | | CurcuminII | ChEBI | | Feruloyl-p-hydroxycinnnamoylmethane | ChEBI | | Monodemethoxycurcumin | MeSH | | Curcumin II | MeSH | | Demethoxy-curcumin | MeSH | | 1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, 9ci | HMDB | | P-Hydroxycinnamoylferuloylmethane | HMDB |
|
|---|
| Chemical Formula | C20H18O5 |
|---|
| Average Molecular Weight | 338.3539 |
|---|
| Monoisotopic Molecular Weight | 338.115423686 |
|---|
| IUPAC Name | (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione |
|---|
| Traditional Name | (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione |
|---|
| CAS Registry Number | 22608-11-3 |
|---|
| SMILES | COC1=CC(\C=C\C(=O)CC(=O)\C=C\C2=CC=C(O)C=C2)=CC=C1O |
|---|
| InChI Identifier | InChI=1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+ |
|---|
| InChI Key | HJTVQHVGMGKONQ-LUZURFALSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as curcuminoids. These are aromatic compounds containing a curcumin moiety, which is composed of two aryl buten-2-one (feruloyl) chromophores joined by a methylene group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Diarylheptanoids |
|---|
| Sub Class | Linear diarylheptanoids |
|---|
| Direct Parent | Curcuminoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Desmethoxycurcumin
- Hydroxycinnamic acid or derivatives
- Methoxyphenol
- Anisole
- Phenoxy compound
- Phenol ether
- Styrene
- Methoxybenzene
- Phenol
- 1,3-diketone
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Benzenoid
- 1,3-dicarbonyl compound
- Monocyclic benzene moiety
- Acryloyl-group
- Alpha,beta-unsaturated ketone
- Enone
- Ketone
- Ether
- Organooxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.71 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.7018 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.9 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2227.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 231.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 171.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 164.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 159.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 594.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 412.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 111.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1267.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 447.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1191.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 335.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 375.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 280.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 208.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 7.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Demethoxycurcumin,1TMS,isomer #1 | COC1=CC(/C=C/C(=O)CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)=CC=C1O | 3373.1 | Semi standard non polar | 33892256 | | Demethoxycurcumin,1TMS,isomer #2 | COC1=CC(/C=C/C(=O)CC(=O)/C=C/C2=CC=C(O)C=C2)=CC=C1O[Si](C)(C)C | 3364.1 | Semi standard non polar | 33892256 | | Demethoxycurcumin,1TMS,isomer #3 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C)=CC=C1O | 3621.5 | Semi standard non polar | 33892256 | | Demethoxycurcumin,1TMS,isomer #4 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C)=CC=C1O | 3600.9 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TMS,isomer #1 | COC1=CC(/C=C/C(=O)CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)=CC=C1O[Si](C)(C)C | 3437.4 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TMS,isomer #2 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)O[Si](C)(C)C)=CC=C1O | 3593.3 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TMS,isomer #3 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)O[Si](C)(C)C)=CC=C1O | 3591.5 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TMS,isomer #4 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3605.1 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TMS,isomer #5 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3586.0 | Semi standard non polar | 33892256 | | Demethoxycurcumin,3TMS,isomer #1 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3620.9 | Semi standard non polar | 33892256 | | Demethoxycurcumin,3TMS,isomer #1 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3591.0 | Standard non polar | 33892256 | | Demethoxycurcumin,3TMS,isomer #2 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3617.6 | Semi standard non polar | 33892256 | | Demethoxycurcumin,3TMS,isomer #2 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O[Si](C)(C)C)C=C2)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3588.4 | Standard non polar | 33892256 | | Demethoxycurcumin,1TBDMS,isomer #1 | COC1=CC(/C=C/C(=O)CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)=CC=C1O | 3682.1 | Semi standard non polar | 33892256 | | Demethoxycurcumin,1TBDMS,isomer #2 | COC1=CC(/C=C/C(=O)CC(=O)/C=C/C2=CC=C(O)C=C2)=CC=C1O[Si](C)(C)C(C)(C)C | 3650.6 | Semi standard non polar | 33892256 | | Demethoxycurcumin,1TBDMS,isomer #3 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O | 3891.7 | Semi standard non polar | 33892256 | | Demethoxycurcumin,1TBDMS,isomer #4 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O | 3864.9 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TBDMS,isomer #1 | COC1=CC(/C=C/C(=O)CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)=CC=C1O[Si](C)(C)C(C)(C)C | 4003.6 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TBDMS,isomer #2 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O | 4184.0 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TBDMS,isomer #3 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O | 4180.1 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TBDMS,isomer #4 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 4150.8 | Semi standard non polar | 33892256 | | Demethoxycurcumin,2TBDMS,isomer #5 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 4131.7 | Semi standard non polar | 33892256 | | Demethoxycurcumin,3TBDMS,isomer #1 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 4401.5 | Semi standard non polar | 33892256 | | Demethoxycurcumin,3TBDMS,isomer #1 | COC1=CC(/C=C/C(=CC(=O)/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 4207.2 | Standard non polar | 33892256 | | Demethoxycurcumin,3TBDMS,isomer #2 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 4401.9 | Semi standard non polar | 33892256 | | Demethoxycurcumin,3TBDMS,isomer #2 | COC1=CC(/C=C/C(=O)C=C(/C=C/C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 4208.3 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Demethoxycurcumin GC-MS (Non-derivatized) - 70eV, Positive | splash10-00r2-0901000000-654fca3f02d69e7560db | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Demethoxycurcumin GC-MS (2 TMS) - 70eV, Positive | splash10-014i-3071900000-50aab8ffd9b366fd14d7 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Demethoxycurcumin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 50V, Positive-QTOF | splash10-0002-0900000000-9517befe911ff515a392 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 10V, Negative-QTOF | splash10-000i-0239000000-696b9f742f1375d511b6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 30V, Negative-QTOF | splash10-014i-0910000000-9ba8139233df2e7399cd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 20V, Negative-QTOF | splash10-014i-0920000000-d6ec1db1bc78454ca02e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 30V, Positive-QTOF | splash10-002b-0910000000-2b60408614dbac128af7 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 40V, Positive-QTOF | splash10-0002-0900000000-5fbd4f101ab8f66c229a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 20V, Positive-QTOF | splash10-0a6s-0961000000-682f6b15c69a852c5c25 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 10V, Positive-QTOF | splash10-000i-0219000000-e3bd2864892e4f6e2318 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 40V, Negative-QTOF | splash10-014i-0910000000-dc9c78751e44dd920a70 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Demethoxycurcumin 50V, Negative-QTOF | splash10-014i-0900000000-0a19a373bd22907fff2f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 10V, Positive-QTOF | splash10-000i-0419000000-127d78c62fb7431896b5 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 20V, Positive-QTOF | splash10-002b-0901000000-c40b24a8778d2fa9787d | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 40V, Positive-QTOF | splash10-002b-1900000000-82aa8b73d450c54c4c30 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 10V, Negative-QTOF | splash10-000i-0309000000-1e9e9a7c9cdc0d078ad5 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 20V, Negative-QTOF | splash10-000j-0914000000-656374264de68ab93dd6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 40V, Negative-QTOF | splash10-07xs-1911000000-d77a4b8103374473002f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 10V, Positive-QTOF | splash10-000i-0709000000-d28143d2357c12a71e64 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 20V, Positive-QTOF | splash10-0002-0901000000-071370f22d66d14d47d2 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 40V, Positive-QTOF | splash10-014j-1910000000-dbecc05d29e924e0b535 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 10V, Negative-QTOF | splash10-014i-0952000000-238d293f45f85e124a77 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 20V, Negative-QTOF | splash10-014r-0913000000-2bcebdb0a036193118c7 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethoxycurcumin 40V, Negative-QTOF | splash10-014r-0912000000-46bf9193d3b8351d3505 | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY: Effects of curcumin and demethoxycurcumin on amyloid-beta precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease. Taiwan J Obstet Gynecol. 2012 Dec;51(4):554-64. doi: 10.1016/j.tjog.2012.09.010. [PubMed:23276558 ]
- Chaneiam N, Changtam C, Mungkongdee T, Suthatvoravut U, Winichagoon P, Vadolas J, Suksamrarn A, Fucharoen S, Svasti S: A reduced curcuminoid analog as a novel inducer of fetal hemoglobin. Ann Hematol. 2013 Mar;92(3):379-86. doi: 10.1007/s00277-012-1604-1. Epub 2012 Oct 19. [PubMed:23079892 ]
- Jitoe-Masuda A, Fujimoto A, Masuda T: Curcumin: from chemistry to chemistry-based functions. Curr Pharm Des. 2013;19(11):2084-92. [PubMed:23116314 ]
- Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY: Curcuminoids and resveratrol as anti-Alzheimer agents. Taiwan J Obstet Gynecol. 2012 Dec;51(4):515-25. doi: 10.1016/j.tjog.2012.09.005. [PubMed:23276553 ]
- Jantan I, Saputri FC, Qaisar MN, Buang F: Correlation between Chemical Composition of Curcuma domestica and Curcuma xanthorrhiza and Their Antioxidant Effect on Human Low-Density Lipoprotein Oxidation. Evid Based Complement Alternat Med. 2012;2012:438356. doi: 10.1155/2012/438356. Epub 2012 Nov 26. [PubMed:23243446 ]
- Kumar A, Bora U: Molecular docking studies on inhibition of Stat3 dimerization by curcumin natural derivatives and its conjugates with amino acids. Bioinformation. 2012;8(20):988-93. doi: 10.6026/97320630008988. Epub 2012 Oct 13. [PubMed:23275693 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
|
|---|